Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1999, p. 3934-3939, Vol. 37, No. 12
Department of Bacteriology and Immunology,
Received 27 April 1999/Returned for modification 3 July
1999/Accepted 9 September 1999
Clonal spread and horizontal transfer in the spread of vancomycin
resistance genes were investigated. Multiplex PCR, pulsed-field gel
electrophoresis (PFGE), hybridization of enterococcal plasmids with the
vanA and vanB probes, and sequencing of a
fragment of vanB were used in the analysis. Before May
1996, 12 vancomycin-resistant Enterococcus faecium (VRE)
isolates were found in Finland. Between May 1996 and October 1997, 156 VRE isolates were found in the Helsinki area. Between December 1997 and
April 1998, fecal samples from 359 patients were cultured for VRE. One
new case of colonization with VRE was found. During the outbreak
period, 88% (137 of 155) of the VRE isolates belonged to two strains
(VRE types I and II), as determined by PFGE. Each VRE type I isolate
possessed vanB, and five isolates also had
vanA. Of the 34 VRE type II isolates, 27 possessed
vanA and 7 possessed vanB. Fifteen of 21 (71%)
ampicillin-resistant, vancomycin-sensitive E. faecium (VSE)
isolates found during and after the outbreak period in one ward were
also of type II. Two VSE type II isolates were found in the hospital
before the outbreak in 1995. By PFGE, the three groups
(vanA, vanB, or no van gene) of
type II shared the same band differences with the main type of VRE type
II with vanA. None of the differences was specific to or
determinative for any of the groups. Our material suggests that
vanA and vanB incorporate into an endemic
ampicillin-resistant VSE strain.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
vanA and vanB Incorporate
into an Endemic Ampicillin-Resistant Vancomycin-Sensitive
Enterococcus faecium Strain: Effect on Interpretation
of Clonality
*
Corresponding author. Mailing address: Department of
Bacteriology and Immunology, Haartman Institute, University of
Helsinki, Haartmaninkatu 3, P.O. Box 21, 00014 Helsinki, Finland.
Phone: 358-0-43461. Fax: 358-0-4346382. E-mail:
JUHANA.SUPPOLA{at}HELSINKI.FI.
Journal of Clinical Microbiology, December 1999, p. 3934-3939, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|